ctrl K

Price Alert

Viridian Therapeutics Inc... (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

18.53

0.09 (0.49%)

At close: Aug 15, 2025, 3:59 PM

18.54

0.05%

After-hours: Aug 15, 2025, 05:32 PM EDT

Viridian Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	99.59M	102.83M	155.58M	42.3M
Short-Term Investments	617.99M	374.54M	268.97M	154.67M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	501K	604K	7.61M	1.49M
Receivables	n/a	102K	102K	451K
Inventory	n/a	n/a	-6.62M	n/a
Other Current Assets	20.88M	9.01M	6.52M	n/a
Total Current Assets	738.46M	486.48M	424.55M	200.16M
Property-Plant & Equipment	3.44M	3.34M	2.94M	2.06M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.94M	3.95M	10.54M	3.55M
Total Assets	742.4M	490.42M	435.09M	203.71M
Account Payables	2.14M	2.24M	14.23M	2.33M
Deferred Revenue	288K	288K	288K	289K
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	45.44M	12.75M	4.87M	6.85M
Total Current Liabilities	47.87M	26.64M	33.35M	13.64M
Long-Term Debt	20.58M	20.2M	4.64M	n/a
Other Long-Term Liabilities	2.02M	989K	1.17M	1.21M
Total Long-Term Liabilities	22.89M	21.77M	6.68M	2.36M
Total Liabilities	70.76M	48.4M	40.03M	15.99M
Total Debt	21.09M	21.05M	5.26M	520K
Common Stock	810K	540K	414K	239K
Retained Earnings	-995.86M	-725.91M	-488.17M	-358.3M
Comprehensive Income	-10K	338K	-390K	-157K
Shareholders Equity	671.64M	442.02M	395.06M	187.72M
Total Investments	617.99M	374.54M	268.97M	154.67M